Want to see GALT full AI Analyst Report?

Galectin Therapeutics (GALT) Revenue

682 Followers

Galectin Therapeutics Revenue

Galectin Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Mar 31, 2026, Galectin Therapeutics had annual revenue of 0.00 with ― growth.

Revenue (ttm)

0.00

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

Employees

Market Cap

$393.31M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	―	―	―
Mar 31, 2025	―	―	―
Dec 31, 2023	―	―	―
Dec 31, 2022	―	―	―
Mar 31, 2022	―	―	―
Mar 31, 2021	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―